Nalepa I, Vetulani J
Institute of Pharmacology, Polish Academy of Sciences, Kraków.
Neuroscience. 1991;44(3):585-90. doi: 10.1016/0306-4522(91)90079-4.
Imipramine did not significantly inhibit the noradrenaline or isoproterenol-induced cyclic AMP accumulation in rat cerebral cortical slices, but inhibited the potentiation of this response by protein kinase C activator, a phorbol ester 12-O-tetradecanoyl-phorbol 13-acetate. In low concentrations (0.1-1 microM) it prevented the inhibitory effect of the phorbol ester on accumulation of inositol phosphate induced by noradrenaline, while in higher concentrations it inhibited the response by itself. Imipramine did not bind to beta-adrenoceptors but was an effective blocking agent of alpha 1-adrenoceptors (Ki = 38.1 nM). The data suggest that imipramine acts within the noradrenergic cyclic AMP generating system on two targets: inhibiting protein kinase C and blocking the alpha 1-adrenoceptor; both actions may reduce the alpha-adrenoceptor potentiation of beta-adrenoceptor-mediated cyclic AMP generation.
丙咪嗪对去甲肾上腺素或异丙肾上腺素诱导的大鼠大脑皮层切片中环磷酸腺苷(cAMP)的积累没有显著抑制作用,但能抑制蛋白激酶C激活剂(佛波酯12 - O - 十四烷酰佛波醇13 - 乙酸酯)对该反应的增强作用。在低浓度(0.1 - 1微摩尔)时,它可防止佛波酯对去甲肾上腺素诱导的肌醇磷酸积累的抑制作用,而在高浓度时,它自身就能抑制该反应。丙咪嗪不与β - 肾上腺素能受体结合,但却是α1 - 肾上腺素能受体的有效阻断剂(抑制常数Ki = 38.1纳摩尔)。这些数据表明,丙咪嗪在去甲肾上腺素能cAMP生成系统中作用于两个靶点:抑制蛋白激酶C和阻断α1 - 肾上腺素能受体;这两种作用可能都会降低α - 肾上腺素能受体对β - 肾上腺素能受体介导的cAMP生成的增强作用。